Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Oct 2006

Balic Marija, Lin Henry, Young Lillian, Hawes Debra, Giuliano Armando, McNamara George, Datar Ram H, Cote Richard J

Abstract excerpt

PURPOSE: The presence of disseminated tumor cells (DTC) in the bone marrow of breast cancer patients is an acknowledged independent prognostic factor. The biological metastatic potential of these cells has not yet been shown. The presence of putative breast cancer stem cells is shown both in primary tumors and distant metastases. These cells with a CD44(+)CD24(-/low) phenotype represent a minor population in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Bone Marrow Examination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Marrow Neoplasms

Share to CD24 Antigen

Share to Hyaluronan Receptors

Share to Immunohistochemistry

Share to Keratins

Share to Neoplastic Stem Cells

Source

Identifiers

PMID: 17020963
DOI: 10.1158/1078-0432.CCR-06-0169

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.PMID 17020963Read ↗

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.Semantic proximity Read ↗

Breast cancer stem cells: current advances and clinical implications.Semantic proximity Read ↗

Breast Cancer Stem Cells: Biomarkers, Identification and Isolation Methods, Regulating Mechanisms, Cellular Origin, and BeyondSemantic proximity Read ↗

The Role of Breast Cancer Stem Cells in Metastasis and Therapeutic ImplicationsSemantic proximity Read ↗

Breast cancer stem cells: are we ready to go from bench to bedside?Semantic proximity Read ↗

Stem Cells and Cellular Origins of Breast Cancer: Updates in the Rationale, Controversies, and Therapeutic ImplicationsSemantic proximity Read ↗

Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypesSemantic proximity Read ↗

Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype.Semantic proximity Read ↗

Prospective identification of tumorigenic breast cancer cellsSemantic proximity Read ↗

CD44(+)/CD24(-) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomas.Semantic proximity Read ↗

Understanding breast cancer stem cell heterogeneity: time to move on to a new research paradigmSemantic proximity Read ↗

Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.